Barely Significant
← all excerpts

Mirabegron Versus Tamsulosin in Reducing Double-J Stent-Related Symptoms: A Prospective Comparative Study.

Cureus · 2025 · PMC12510617 · PMID 41080378

1
hedged sentence
closest p
boldest claim

The sentences

However, mirabegron demonstrated superior relief in urinary symptoms and body pain scores at both two and three weeks (p < 0.001), with trends toward improved general health, sexual function, and work performance domains, although these did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.